RNU6-893P

Across TCGA pan-cancer cohorts, RNU6-893P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-893P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-893P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-893P expression acts as an unfavorable survival marker, although some lineages such as OV show a favorable association.

ACC, UVM, and HNSC are the cancer types where RNU6-893P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	II,III,IV	0.128	0.534	<.001	106	view →
UVM	DFS	Tertile	All	0.173	0.790	<.001	69	view →
HNSC	OS	Tertile	IV	0.376	0.623	.010	51	view →
OV	OS	Quartile	All	0.929	0.812	.002	36	view →
READ	DFS	Tertile	III,IV	0.174	0.747	.005	36	view →
DLBC	OS	Quartile	II,III,IV	0.709	0.981	.003	21	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
KIRC	DFS	Tertile	III,IV	0.348	0.536	.018	17	view →
MESO	DFS	Tertile	IV	0.071	0.359	.009	9	view →
GBM	DFS	Tertile	All	0.189	0.278	.044	9	view →
KICH	DFS	Tertile	All	0.646	0.944	.024	8	view →
BLCA	OS	Tertile	All	0.537	0.710	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-893P–ACC (DFS)

Open the ACC breakdown →